EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Micromem Technologies Inc.: Exhibit 99.1 - Filed by newsfilecorp.com

 

Micromem Technologies Inc.

Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States Dollars)

 


Micromem Technologies Inc.

Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States Dollars)

 

Contents

Notice to Shareholders 1
   
Unaudited Condensed Interim Consolidated Financial Statements:  
   
Unaudited Condensed Interim Consolidated Statements of Financial Position 2
   
Unaudited Condensed Interim Consolidated Statements of Operations and Comprehensive Loss 3
   
Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders' Deficiency 4
   
Unaudited Condensed Interim Consolidated Statements of Cash Flows 5
   
Notes to the Unaudited Condensed Interim Consolidated Financial Statements 6


Micromem Technologies Inc.

Unaudited Condensed Interim Consolidated Financial Statements

Notice of no auditor review of the condensed interim consolidated financial statements

Under National Instrument 51-102, Part 4, subsection 4.3(3)(a), if an auditor has not performed a review of the condensed interim consolidated financial statements, they must be accompanied by a notice indicating that the condensed interim consolidated financial statements have not been reviewed by an auditor.

The accompanying unaudited condensed interim consolidated financial statements of Micromem Technologies Inc. (the "Company") have been prepared by and are the responsibility of the Company's management and

The Company's independent auditor has not performed a review of these condensed interim consolidated financial statements in accordance with the standards established by the Chartered Professional Accountants of Canada, for a review of condensed interim consolidated financial statements by an entity's auditor.

 

March 6, 2024

 


Micromem Technologies Inc.

Unaudited Condensed Interim Consolidated Statements of Financial Position

As at January 31, 2024 and October 31, 2023

(Expressed in United States dollars)

          As at     As at  
    Notes     January 31, 2024     October 31, 2023  
                   
Assets                  
Current                  
Cash   20(a)   $ 34,189   $ 31,584  
Prepaid expenses and other receivables   18     82,245     103,999  
Total current assets         116,434     135,583  
Property and equipment   5     28,393     32,767  
Total assets       $ 144,827   $ 168,350  
                   
Liabilities                  
Current                  
Trade payables and other liabilities   17 (b)   $ 234,977   $ 209,285  
Deposit liability   18     63,000     63,000  
Current lease liability   6     18,148     17,036  
Debenture payable   7     38,836     37,509  
Convertible debentures   9     3,725,348     3,548,059  
Derivative liabilities   9     2,031,898     1,079,393  
Total current liabilities         6,112,207     4,954,282  
Non-current lease liability   6     7,698     12,018  
Long-term loan   8     26,906     43,254  
Total liabilities         6,146,811     5,009,554  
                   
Shareholders' Deficiency                  
Share capital   10     90,721,719     90,471,712  
Contributed surplus         24,876,905     24,868,843  
Equity component of convertible debentures   9     3,221,136     3,220,473  
Accumulated deficit         (124,821,744 )   (123,402,232 )
Total shareholders' deficiency         (6,001,984 )   (4,841,204 )
Total liabilities and shareholders' deficiency       $ 144,827   $ 168,350  
                   
Going concern   2              
Contingencies   18              
Subsequent events   20              

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.

Approved on behalf of the Board of Directors:

 

 

     

"Joseph Fuda"

 

"Alex Dey"

Director

 

Director



Micromem Technologies Inc.

Unaudited Condensed Interim Consolidated Statements of Operations and Comprehensive Loss

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars)

          Three months ended January 31,  
             
    Notes     2024     2023  
                   
Operating expenses                  
General and administrative   15(a)   $ 30,576   $ 26,414  
Professional, other fees and salaries   15(b)     117,336     81,170  
Stock-based compensation   12     6,517     5,692  
Travel and entertainment         6,576     7,805  
Depreciation of property and equipment   5     4,150     4,095  
Foreign exchange loss         98,227     58,504  
Total operating expenses         263,382     183,680  
                   
Other expenses (income)                  
Accretion expense   8, 9     31,637     79,762  
Interest expense on convertible debt   9     140,408     131,136  
Other finance expenses   6, 7,9     3,715     3,252  
Loss (gain) on revaluation of derivative liabilities   9     584,900     (304,849 )
Loss on conversion of convertible debentures   9     10,345     8,779  
Loss (gain) on repayment of convertible debentures   9     51,663     (5,667 )
Loss on extinguishment of convertible debentures   9     334,462     120,237  
Total other expenses         1,157,130     32,650  
Loss before income tax provision         (1,420,512 )   (216,330 )
Income tax provision   14     -     -  
Net loss and comprehensive loss       $ (1,420,512 ) $ (216,330 )
                   
Weighted average number of outstanding shares, basic and diluted   13     513,580,575     468,323,158  
                   
Loss per share, basic and diluted   13   $ -   $ -  

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.


Micromem Technologies Inc.

Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders' Deficiency

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars)

                            Equity              
                            component of              
          Number of           Contributed     convertible     Accumulated        
    Notes     shares     Share capital     surplus     debentures     deficit     Total  
                                           
Balance at November 1, 2023         510,368,838   $ 90,471,712   $ 24,868,843   $ 3,220,473   $ (123,402,232 ) $ (4,841,204 )
Private placements of shares for cash   10     2,400,000     112,673     -     -     -     112,673  
Share issuance costs   10     -     (6,884 )   -     -     -     (6,884 )
Broker warrants issued   10, 11     -     (3,208 )   3,208     -     -     -  
Expiry of stock options   12     -     -     (1,000 )   -     1,000     -  
Convertible debentures converted into common shares   9     3,780,426     147,426     -     -     -     147,426  
Expiry of convertible debenture conversion option   9     -     -     2,178,358     (2,178,358 )   -     -  
Renewal of convertible debentures   9     -     -     (2,179,021 )   2,179,021     -     -  
Stock-based compensation   12     -     -     6,517     -     -     16,517  
Net loss and comprehensive loss for the period         -     -     -     -     (1,420,512 )   (1,420,512 )
Balance at January 31, 2024         516,549,264   $ 90,721,719   $ 24,876,905   $ 3,221,136   $ (124,821,744 ) $ (6,001,984 )
                                           
Balance at November 1, 2022         467,607,678   $ 87,784,725   $ 27,459,730   $ 793,140   $ (120,785,595 ) $ (4,748,000 )
Private placements of shares for cash   10     1,000,000     37,080     -     -     -     37,080  
Convertible debentures converted into common shares   9     3,788,177     107,774     -     -     -     107,774  
Expiry of convertible debenture conversion option   9     -     -     507,108     (507,108 )   -     -  
Renewal of convertible debentures   9     -     -     (529,496 )   529,496     -     -  
Stock-based compensation   12     -     -     5,692     -     -     5,692  
Net loss and comprehensive loss for the period         -     -     -     -     (216,330 )   (216,330 )
Balance at January 31, 2023         472,395,855   $ 87,929,579   $ 27,443,034   $ 815,528   $ (121,001,925 ) $ (4,813,784 )

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.


Micromem Technologies Inc.

Unaudited Condensed Interim Consolidated Statements of Cash Flows

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars)

          Three months ended  
          January 31,  
    Notes     2024     2023  
Operating activities                  
Net loss       $ (1,420,512 ) $ (216,330 )
Items not affecting cash:                  
Depreciation of property and equipment   5     4,150     4,095  
Government grant   8     (17,868 )   -  
Accretion expense   8,9     31,637     79,762  
Accrued interest on convertible debentures   9     120,983     113,846  
Stock-based compensation   12     6,517     5,692  
Loss on conversion of convertible debentures   9     10,345     8,779  
Loss (gain) on repayment of convertible debentures   9     51,663     (5,667 )
Loss (gain) on revaluation of derivative liabilities   9     584,900     (304,849 )
Loss on extinguishment of convertible debentures   9     271,199     120,237  
Foreign exchange loss         79,179     52,780  
          (277,807 )   (141,655 )
Net changes in non-cash working capital:                  
Prepaid expenses and other receivables         21,754     (998 )
Trade payables and other liabilities         25,692     (1,928 )
Cash flows used in operating activities         (230,361 )   (144,581 )
                   
Financing activities                  
Principal payments on lease liability   6     (4,198 )   (3,747 )
Private placements of shares for cash   10     112,673     37,080  
Share issuance costs         (6,884 )   -  
Proceeds from issuance of convertible debentures   16     304,501     125,600  
Repayments of convertible debentures   9     (173,126 )   (5,000 )
Cash flows provided by financing activities         232,966     153,933  
                   
Net change in cash         2,605     9,352  
Cash - beginning of period         31,584     33,227  
Cash - end of period       $ 34,189   $ 42,579  
                   
Supplemental cash flow information                  
Repayment penalties (classified in operating activites)       $ 63,263   $ -  
Interest paid (classified in operating activities)   9   $ 17,609   $ 15,418  
Interest converted (classified in operating activities)   9   $ 1,816   $ -  
Interest paid on non-convertible debt (classified in operating activities)   7   $ 2,285   $ 2,292  
Interest paid on lease liability (classified in operating activities)   6   $ 603   $ 960  
Carrying amount of convertible debentures converted into common shares   9   $ 147,426   $ 107,774  

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

1. Reporting entity and nature of business

Micromem Technologies Inc. ("Micromem" or the "Company") is incorporated under the laws of the Province of Ontario, Canada. Micromem is a publicly traded company with its head office located at 121 Richmond Street West, Suite 602, Toronto, Ontario, Canada. The Company's common shares are currently listed on the Canadian Securities Exchange under the trading symbol "MRM" and on the Over the Counter Venture Market under the trading symbol "MMTIF".

The Company develops, based upon proprietary technology, customized sensor applications for companies (referred to as "Development Partners") operating internationally in various industry segments. The Company has not generated commercial revenues through January 31, 2024 and is devoting substantially all its efforts to securing commercial revenue opportunities.

2. Going concern

These unaudited condensed interim consolidated financial statements have been prepared with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

There are material uncertainties related to conditions and events that cast substantial doubt about the Company's ability to continue as a going concern and ultimately on the appropriateness of the use of the accounting principles applicable to a going concern. During the three months ended January 31, 2024, the Company reported a net loss and comprehensive loss of $1,420,512 (2023 - $216,330) and negative cash flow from operations of $230,361 (2023 - $144,581). The Company's working capital deficiency as at January 31, 2024 was $5,995,773 (October 31, 2023 - $4,818,699).

The Company's success depends on the profitable commercialization of its proprietary sensor technology. Based upon its current operating and financial plans, management of the Company believes that it will have sufficient access to financial resources to fund the Company's planned operations through the next twelve months; however, the ability of the Company to continue as a going concern is dependent upon its ability to secure additional financing and/or to profitably commercialize its technology. There is no assurance that the Company will be successful in the profitable commercialization of its technology, or will be able to secure the necessary additional financing. These unaudited condensed interim consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern. If the going concern assumption was not appropriate for these unaudited condensed interim consolidated financial statements then adjustments could be necessary to the carrying value of assets and liabilities, the reported expenses and the statement of financial position classifications used; in such cases, these adjustments could be material.

3. Basis of presentation

These unaudited condensed interim consolidated financial statements for the three months ended January 31, 2024 and 2023 have been prepared in accordance with International Accounting Standard ("IAS") 34 Interim Financial Reporting. The accounting policies and methods of computation adopted in the preparation of the unaudited condensed interim consolidated financial statements are consistent with those followed in the preparation of the Company's audited annual consolidated financial statements for the year ended October 31, 2023. The Company has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.

These unaudited condensed interim consolidated financial statements were authorized for issuance and release by the Company's Board of Directors on March 6, 2024.

(a) Basis of consolidation

These unaudited condensed interim consolidated financial statements include the accounts of Micromem Technologies Inc. and its subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation.

The Company's wholly-owned subsidiaries include:

(i)

Inactive subsidiaries

 

Domiciled in

 

Micromem Applied Sensors Technology Inc. ("MAST")

 

United States

 

707019 Canada Inc.

 

Canada

 

Memtech International Inc.

 

Bahamas

 

Memtech International (USA) Inc., Pageant Technologies (USA) Inc.

 

United States

 

Pageant Technologies Inc., Micromem Holdings (Barbados) Inc.

 

Barbados



Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

3. Basis of presentation (continued)

(b) Basis of measurement

These unaudited condensed interim consolidated financial statements have been prepared on the historical cost basis, except for financial instruments designated at fair value through profit and loss which are measured at their fair value.

(c) Functional and presentation currency

These unaudited condensed interim consolidated financial statements are presented in United States dollars ("USD"), which is the functional currency of the Company and all of its subsidiaries.

(d) Use of estimates and judgments

The preparation of these unaudited condensed consolidated interim financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited condensed interim consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. These estimates are reviewed periodically and adjustments are made as appropriate in the reporting period they become known. Items for which actual results may differ materially from these estimates are described in the following section.

(i) Fair value of options and conversion features

The Company makes estimates and utilizes assumptions in determining the fair value for stock options and conversion features based on the application of the Black-Scholes option pricing model or the binomial option pricing model, depending on the circumstances. These pricing models require management to make various assumptions and estimates that are susceptible to uncertainty, including the volatility of the share price, expected dividend yield, expected term, risk-free interest rate, and exercise price in the binomial option pricing model.

(ii) Useful lives and recoverability of long-lived assets

Long-lived assets consist of property and equipment. Depreciation is dependent upon estimates of useful lives and impairment is dependent upon estimates of recoverable amounts. These are determined through the exercise of judgment and are dependent upon estimates that take into account factors such as economic and market conditions, frequency of use, anticipated changes in laws, and technological improvements.

(iii) Income taxes

Income taxes and tax exposures recognized in the unaudited condensed interim consolidated financial statements reflect management's best estimate of the outcome based on facts known at the reporting date. When the Company anticipates a future income tax payment based on its estimates, it recognizes a liability. The difference between the expected amount and the final tax outcome has an impact on current and deferred taxes when the Company becomes aware of this difference.

When the Company incurs losses for income tax purposes, it assesses the probability of taxable income being available in the future, based on budgeted forecasts. These forecasts are adjusted for certain non-taxable income and expenses and specific rules on the use of unused credits and tax losses. When the forecasts indicate that sufficient future taxable income will be available to deduct the temporary differences, a deferred tax asset is recognized for all deductible temporary differences.

(iv) Going concern assumption

The Company applies judgment in assessing whether material uncertainties exist that would cause doubt as to the whether the Company could continue as a going concern.


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

4. New and revised standards and interpretations

Certain pronouncements were issued by the IASB or the IFRIC that are mandatory for accounting periods commencing on or after November 1, 2023. The Company has adopted these pronouncements as of their effective date, and many are not applicable or do not have a significant impact on the Company and have been excluded.

The following amendments were issued but not yet effective. The Company will adopt these amendments as of their effective dates. The Company is currently assessing the impacts of adoption.

(a) Amendments to IAS 1, Presentation of Financial Statements

IAS 1 was amended in January 2020 to provide a more general approach to the classification of liabilities under IAS 1 based on the contractual arrangements in place at the reporting date. The amendments clarify that the classification of liabilities as current or noncurrent is based solely on a company's right to defer settlement at the reporting date. The right needs to be unconditional and must have substance. The amendments also clarify that the transfer of a company's own equity instruments is regarded as settlement of a liability, unless it results from the exercise of a conversion option meeting the definition of an equity instrument. The amendments are effective for annual periods beginning on January 1, 2024. Earlier adoption is permitted. The Company will adopt this amendment as of the effective date, and does not anticipate any material impacts on adoption.

(b) Amendments to IFRS 10, Consolidated Financial Statements and IAS 28, Investments in Associates and Joint Ventures

IFRS 10 and IAS 28 were amended in September 2014 to address a conflict between the requirements of IAS 28 and IFRS 10 and clarify that in a transaction involving an associate or joint venture, the extent of gain or loss recognition depends on whether the assets sold or contributed constitute a business. The effective date of these amendments is yet to be determined, however early adoption is permitted.

5. Property and equipment

    As at                 As at  
    November 1,                 January 31,  
    2023     Additions     Foreign exchange     2024  
Cost                        
Computers $ 9,510   $ -   $ -   $ 9,510  
Right-of-use assets   48,408     -     -   $ 48,408  
    57,918     -     -     57,918  
Accumulated depreciation                        
Computers   4,981     324   $ 16     5,321  
Right-of-use assets   20,170     3,826     208     24,204  
    25,151     4,150     224     29,525  
Net book value $ 32,767               $ 28,393  

6. Leases

(a) As a lessee

The lease obligation relates to the use of office space in Toronto, Ontario. On May 26, 2022, a new lease agreement was entered into for a term from August 1, 2022 to July 31, 2025 for office space in another location in Toronto, Ontario. The present value of the lease obligation was calculated using a discount rate of 9%.

Continuity schedule of lease obligation

Balance, October 31, 2023 $ 29,054  
Interest expense   603  
Lease payments   (4,801 )
Foreign exchange   990  
Balance, January 31, 2024 $ 25,846  


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

6. Leases (continued)

(a) As a lessee (continued)

The following represents a maturity analysis of the Company's undiscounted contractual lease obligations as at January 31, 2024:

    USD  
Less than one year $ 19,595  
Between one and five years $ 8,255  

(b) As a lessor

The Company sub-leases a portion of its office space under a lease agreement for a term of three years, expiring July 31, 2025. The sub-lease is classified as an operating lease because it does not transfer substantially all of the risks and rewards incidental to ownership of the asset.

For the three months ended January 31, 2024, the Company recognized a total of $4,557 (2023 - $4,386) as rental income which has been recorded as a reduction to general and administrative expenses on the unaudited condensed interim consolidated statement of operations and comprehensive loss.

The following represents a maturity analysis of the Company's lease payments to be received after January 31, 2024:

    USD  
Less than one year $ 9,798  
Between one and five years $ 4,127  

7. Debenture payable

The Company issued a debenture on March 17, 2020, with a principal amount of $51,500 CAD ($37,126 USD) and an original maturity date of June 17, 2020. The debenture's maturity date was extended by six month intervals on June 17, 2020, December 17, 2020, June 17, 2021, December 17, 2021, June 17, 2022, December 17, 2022, June 17, 2023 and December 17, 2023. The most recent extension on December 17, 2023 extended the debenture to June 17, 2024. The extension of the debenture's maturity date resulted in a substantial modification of the existing terms of the debenture and accordingly was accounted for as an extinguishment. The debenture bears interest at a rate of 24% and is unsecured. At January 31, 2024, the debenture had an outstanding balance of $38,836 ($52,031 CAD) (October 31, 2023 - $37,509 ($52,031 CAD)). During the three months ended January 31, 2024, total interest expense of $2,285 (2023 -$2,292) was recognized in the unaudited condensed interim consolidated statement of operations and comprehensive loss.

8. Long-term loan

The Company was granted a $60,000 CAD ($44,784 USD) interest-free loan from the Government of Canada under the Canada Emergency Business Account ("CEBA") program to cover its operating costs (the "CEBA Loan"). If the Company repaid $40,000 CAD ($28,836 USD) of the aggregate amount advanced on or before January 18, 2024, the repayment of the remaining $20,000 CAD would be forgiven. The balance was not paid by January 18, 2024, and as a result, on January 19, 2024 the CEBA loan was converted to a 3-year term loan, bearing interest at 5% per annum, paid monthly. The total principal balance plus any accrued and unpaid interest is payable in full on December 31, 2026.

The conversion of the interest-free loan into an interest-bearing 3 year term loan resulted in a substantial modification of the existing terms of the CEBA loan and accordingly was accounted for as an extinguishment. On January 19, 2024, the CEBA loan was recognized at fair value using a market rate of interest of 24%. The difference between this discounted value of $35,841 CAD ($25,386 USD) and the carrying amount of $60,000 CAD ($43,254 USD) was recognized as a government grant of $24,159 CAD ($17,868 USD) in the unaudited condensed interim consolidated statement of operations and comprehensive loss.

The continuity of the long-term loan is summarized as follows:

Balance, October 31, 2023 $ 43,254  
Government grant   (17,868 )
Fair value on January 19, 2024   25,386  
Accretion expense   153  
Foreign exchange   1,367  
Balance, January 31, 2024 $ 26,906  


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

9. Convertible debentures

The Company issues three types of convertible debentures: USD denominated convertible debentures with an equity component, Canadian dollar ("CAD") denominated convertible debentures with an embedded derivative due to variable consideration payable upon conversion caused by foreign exchange, and USD denominated convertible debentures with an embedded derivative caused by variable conversion prices.

During the three months ended January 31, 2024, the Company incurred $63,263 of financing costs (2023 - $nil) which primarily consisted of early repayment and administrative fees, of which $nil (2023 - $nil) was converted into common shares. All loan principal amounts and conversion prices are expressed in original currency and all remaining dollar amounts are expressed in USD.

(a) Current period information presented in the unaudited condensed interim consolidated financial statements

Convertible debentures outstanding as at January 31, 2024:

    USD
(equity
component)
    CAD (embedded
derivative)
 
    USD (embedded
derivative)
    Total  
Loan principal outstanding $ 1,348,905   $ 2,217,086   $ 412,501        
                         
Terms of loan                        
Annual stated interest rate   12% - 24%     12% - 24%     2% - 4%        
Effective annual interest rate   24%     22 - 131%     24% - 4414%        
Conversion price to common shares $ 0.03 - $0.04   $ 0.05 - $0.10     (i) - (ii)        
Remaining life (in months)   0 - 6     0 - 12     0 - 12        
                         
Unaudited Condensed Interim Consolidated Statement of Financial Position  
Carrying value of loan principal $ 1,347,454   $ 1,547,634   $ 101,977   $ 2,997,065  
Interest payable   329,587     366,213     32,483     728,283  
Convertible debentures $ 1,677,041   $ 1,913,847   $ 134,460   $ 3,725,348  
Derivative liabilities $ -   $ 1,746,463   $ 285,435   $ 2,031,898  
Equity component of convertible debentures $ 3,221,136   $ -   $ -   $ 3,221,136  

For the three months ended January 31, 2024:

    USD
(equity
component)
    CDN (embedded
derivative)
    USD (embedded
derivative)
    Total  
Unaudited Condensed Interim Consolidated Statement of Operations and Comprehensive Loss              
Accretion expense $ 1,368   $ 20,083   $ 10,033   $ 31,484  
Interest expense $ 75,562   $ 61,130   $ 3,716   $ 140,408  
(Gain) loss on revaluation of derivative liabilities $ -   $ 661,303   $ (76,403 ) $ 584,900  
Loss on conversion of convertible debentures $ -   $ -   $ 10,345   $ 10,345  
Loss on repayment of convertible debentures $ -   $ -   $ 51,663   $ 51,663  
Loss on extinguishment of convertible debentures $ -   $ 252,269   $ 82,193   $ 334,462  
               
Unaudited Condensed Interim Consolidated Statement of Changes in Equity              
Amount of principal converted to common shares $ -   $ 60,000   $ 93,600        
Amount of interest converted to common shares $ -   $ 197   $ 1,872        
Number of common shares issued on conversion of convertible debentures   -     1,203,945     2,576,481     3,780,426  
         
Unaudited Condensed Interim Consolidated Statement of Cash Flows        
Amount of principal repaid in cash $ -   $ -   $ 173,126   $ 173,126  
Amount of interest repaid in cash $ 3,614   $ 13,995   $ -   $ 17,609  

(i) Conversion price defined as 75% multiplied by the average of the lowest 3 closing stock prices for the 10 trading days prior to conversion date.

(ii) Conversion price defined as 75% multiplied by the lowest stock price for the 20 trading days prior to conversion date.


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

9. Convertible debentures (continued)

(b) Comparative information presented in the unaudited condensed interim consolidated financial statements

Convertible debentures outstanding as at October 31, 2023:

    USD
(equity
component)
    CAD (embedded
derivative)
    USD (embedded
derivative)
    Total  
Loan principal outstanding $ 1,261,265   $ 2,146,715   $ 405,001        
                         
Terms of loan                        
Annual stated interest rate   24%     12% - 24%     2% - 4%        
Effective annual interest rate   24%     22% - 131%     24% - 5158%        
Conversion price to common shares $ 0.03 - $0.04   $ 0.05 - $0.10     (i) - (ii)        
Remaining life (in months)   0 - 4     0 - 11     0 - 11        
                     
Unaudited Condensed Interim Consolidated Statement of Financial Position                    
Carrying value of loan principal $ 1,261,265   $ 1,499,667   $ 77,238   $ 2,838,170  
Interest payable   344,993     334,511     30,385     709,889  
Convertible debentures $ 1,606,258   $ 1,834,178   $ 107,623   $ 3,548,059  
                         
Derivative liabilities $ -   $ 783,650   $ 295,743   $ 1,079,393  
Equity component of convertible debentures $ 3,220,473   $ -   $ -   $ 3,220,473  

(i) Conversion price defined as 75% multiplied by the average of the lowest 3 closing stock prices for the 10 trading days prior to conversion date.

(ii) Conversion price defined as 75% multiplied by the lowest stock price for the 20 trading days prior to conversion date.

For the three months ended January 31, 2023:

    USD
(equity
component)
    CAD (embedded
derivative)
    USD (embedded
derivative)
    Total  
               
Unaudited Condensed Interim Consolidated Statement of Operations and Comprehensive Loss              
Accretion expense $ 6,866   $ 59,043   $ 13,853   $ 79,762  
Interest expense $ 66,304   $ 61,507   $ 3,325   $ 131,136  
(Gain) on revaluation of derivative liabilities $ -   $ (255,794 ) $ (49,055 ) $ (304,849 )
Loss on conversion of convertible debentures $ -   $ -   $ 8,779   $ 8,779  
(Gain) on repayment of convertible debentures $ -   $ -   $ (5,667 ) $ (5,667 )
(Gain) loss on extinguishment of convertible debentures $ (11,203 ) $ 108,713   $ 22,727   $ 120,237  
                         
Unaudited Condensed Interim Consolidated Statement of Changes in Equity                    
Amount of principal converted to common shares $ -   $ -   $ 93,600        
Amount of interest converted to common shares $ -   $ -   $ 1,872        
Number of common shares issued on conversion of convertible debentures   -     -     3,788,177     3,788,177  
                         
Unaudited Condensed Interim Consolidated Statement of Cash Flows                    
Amount of principal repaid in cash $ -   $ -   $ 5,000   $ 5,000  
Amount of interest repaid in cash $ 2,846   $ 12,572   $ -   $ 15,418  


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

9. Convertible debentures (continued)

(c) Fair value of derivative liabilities outstanding


  As at   As at
  January 31,   October 31,
  2024   2023
Share price $0.08   $0.05
Exercise price $0.03 - $0.07   $0.03 - $0.07
Volatility factor (based on historical volatility) 89% - 170%   114% - 189%
Risk free interest rate 4.85% - 5.33%   5.11% - 5.48%
Expected life of conversion features (in months) 0 - 12   0 - 11
Expected dividend yield 0%   0%
CAD to USD exchange rate (as applicable) 0.7464   0.7209
Call value $0.02 - $0.05   $0.01 - $0.08

Volatility was estimated using the historical volatility of the Company's stock prices for common shares.

10. Share capital

(a) Authorized and outstanding shares

The Company has two classes of shares as follows:

(i) Special redeemable voting preference shares - 2,000,000 authorized, nil issued and outstanding.

(ii) Common shares without par value - an unlimited number authorized. The holders of the common shares are entitled to receive dividends which may be declared from time to time, and are entitled to one vote per share at shareholder meetings of the Company. All common shares are ranked equally with regards to the Company's residual assets.

(b) Private placements

During the three months ended January 31, 2024, the Company completed 2 private placements (2023 - 2 private placements), pursuant to prospectus and registration exemptions set forth in applicable securities law. The Company received net proceeds of $105,789 (2023 - $37,080) and issued a total of 2,400,000 (2023 - 1,000,000) common shares.

11. Warrants

On December 22, 2023, the Company issued 63,000 broker warrants in connection with its private placement, as described in Note 10 (b). The broker warrants can be exercised at any time, on a one for one basis, at a price of $0.07 ($0.095 CAD) per share, until December 22, 2025.

The Company uses the Black-Scholes pricing model to estimate fair value. Expected volatility has been based on an evaluation of the historical volatility of the Company's share price. The risk-free interest rate for the life of the warrants was based on the yield available on government benchmark bonds with an approximate equivalent remaining term at the time of issue. The life of the warrant is based on the contractual term.

 

December 22, 2023

Share price and Exercise price

$0.07 ($0.095 CAD)

Volatility factor (based on historical volatility)

146%

Risk free interest rate

4.02%

Expected life of conversion features (in years)

2

Expected dividend yield

0%

The following table summarizes the warrants outstanding and exercisable as at January 31, 2024:

Expiry date Number of warrants Weighted average exercise price Remaining contractual life
December 22, 2025 63,000 $0.07 ($0.095 CAD) 1.89 years


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

12. Stock options

(a) Stock option plan

Under the Company's fixed stock option plan (the "Plan"), the Company could grant up to 27,500,000 shares of common stock to directors, officers, employees or consultants of the Company and its subsidiaries. The exercise price of each option is equal to or greater than the market price of the Company's shares on the date of grant unless otherwise permitted by applicable securities regulations. An option's maximum term under the Plan is 10 years. Stock options are fully vested upon issuance by the Company unless the Board of Directors stipulates otherwise by Directors' resolution.

(b) Summary of changes


    Number of     Weighted average  
    options     exercise price  
Outstanding at October 31, 2023   9,775,000   $ 0.06  
Expired   (25,000 )   (0.07 )
Outstanding at January 31, 2024   9,750,000   $ 0.06  

    Number of     Weighted average  
    options     exercise price  
Outstanding at October 31, 2022   11,725,000   $ 0.06  
Granted   -     -  
Outstanding at January 31, 2023   11,725,000   $ 0.06  

(c) Stock options outstanding at January 31, 2024

          Options     Options     Weighted average  
                Remaining  
Date of issue   Expiry date     outstanding     exercisable     Exercise price     contractual life  
November 13, 2020   November 13, 2025     5,750,000     5,750,000     0.05     1.8  
October 8, 2021   October 8, 2026     1,000,000     1,000,000     0.07     2.7  
March 20, 2023   March 20, 2028     2,000,000     2,000,000     0.07     4.1  
April 6, 2023   April 6, 2024     1,000,000     1,000,000     0.07     0.2  
As at January 31, 2024         9,750,000     9,750,000   $ 0.06     2.2  

During the three months ended January 31, 2024, the Company recorded an expense of $6,517 for the vesting of stock options (2023 - $5,692).

13. Loss per share

 

 

Net loss attributable to common shareholders and used in computation of basic and diluted loss per share

 

 

    Three months ended January 31,  
Numerator   2024     2023  
Basic and diluted loss per share are calculated using the following numerators and denominators: $ (1,420,512 ) $ (216,330 )
             
Denominator            
Weighted average number of common shares for computation of basic and diluted loss per share   513,580,575     468,323,158  

For the three months ended January 31, 2024 and 2023, all stock options and conversion features were anti-dilutive and, therefore, are excluded from the calculation of diluted loss per share.


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

14. Income taxes

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and amounts used for income tax purposes.

As at January 31, 2024, the Company has non-capital losses of approximately $33 million, $28.8 million in Canada and $4.4 million in other foreign jurisdictions, available to reduce future taxable income. Non-capital losses expire commencing in 2026. In addition, the Company has available capital loss carry forwards of approximately $1.2 million to reduce future taxable capital gains. Capital losses carry forward indefinitely.

As at January 31, 2024, and October 31, 2023, the Company assessed that it is not probable that sufficient taxable income will be available to use deferred income tax assets based on operating losses in prior years; therefore, there are no balances recognized in the unaudited condensed interim consolidated statements of financial position for such assets.

15. Operating expenses

(a) General and administration

The components of general and administration expenses are as follows:

    Notes     Three months ended January 31,  
    2024     2023  
General and administration   6   $ 8,493   $ 17,602  
Investor relations, listing and filing fees         20,466     7,727  
Telephone         1,617     1,085  
        $ 30,576   $ 26,414  

(b) Professional, other fees and salaries

The components of professional, other fees and salaries expenses are as follows:


    Three months ended January 31,  
    2024     2023  
Professional and consulting fees $ 69,701   $ 31,518  
Salaries and benefits   47,635     49,652  
  $ 117,336   $ 81,170  

16. Supplemental cash flow information

The following provides a reconciliation of the cash flows from convertible debentures and derivative liabilities :

    Three months ended January 31,  
    2024     2023  
Balance - beginning of period $ 4,627,452   $ 4,433,363  
Cash flows from financing activities:            
Proceeds from issuance of convertible debentures   304,501     125,600  
Repayments of convertible debentures   (173,126 )   (5,000 )
Non-cash changes:            
Accretion expense   31,484     79,762  
Accrued interest on convertible debentures   120,983     113,846  
Loss (gain) on repayment of convertible debentures   51,663     (5,667 )
Loss on conversion of convertible debentures   10,345     8,779  
Loss (gain) on revaluation of derivative liabilities   584,900     (304,849 )
Loss on extinguishment of convertible debt   271,199     120,237  
Convertible debentures converted into common shares   (147,426 )   (107,774 )
Foreign exchange loss   75,271     49,298  
Balance - end of period $ 5,757,246   $ 4,507,595  


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

17. Key management compensation and related party transactions

The Company reports the following related party transactions:

(a) Key management compensation

Key management personnel are persons responsible for planning, directing and controlling activities of the Company, including officers and directors. Compensation paid or payable to these individuals (or companies controlled by such individuals) are summarized as follows:

    Three months ended January 31,  
    2024     2023  
Professional, other fees, and salaries $ 29,658   $ 9,761  
  $ 29,658   $ 9,761  

During the three months ended January 31, 2024 and 2023, key management were not awarded any options.

(b) Trade payables and other liabilities

Included in accounts payable at January 31, 2024 is $nil payable to a director (October 31, 2023 - $2,173).

18. Contingencies

(a) The Company has agreed to indemnify its directors and officers and certain of its employees in accordance with the Company's by-laws. The Company maintains insurance policies that may provide coverage against certain claims.

(b) The Company has previously reported on the lawsuit filed by Mr. Steven Van Fleet against Micromem, the Company's response to the lawsuit and its counterclaims against Mr. Van Fleet.

On April 29, 2021 the matter was resolved in Micromem's favor when the Court dismissed Mr. Van Fleet's claims and ruled that he was liable to the Company and to MAST on their counterclaims. On June 16, 2021, the Court ruled that Micromem and MAST had established damages totaling $765,579 representing the full amount that had been requested; furthermore, the Court awarded costs and statutory prejudgment interest from May 9, 2017. On June 29, 2021 the Court entered a judgement in favor of Micromem and MAST for a total amount of $1,051,739.

With respect to the Company's efforts to collect on that Judgement, a settlement ("Settlement") was reached during October 2021. Pursuant to the Settlement, the Company received an initial one-time payment and is entitled to additional monthly payments over a period of up to six years. The Company will record those payments as and when they are received. The total amount to be received by the Company if Mr. Van Fleet makes all the required payments under the terms of the Settlement will be less than the amount of the Judgement obtained by the Company, but if Mr. Van Fleet does not comply with the terms of the Settlement, it also provides the Company a means of enforcing a larger judgement against Mr. Van Fleet that is substantially in line with the Judgement. Mr. Van Fleet has made the prescribed monthly payments each month since October 2021.

The Company reports the recovery of this contingent asset as funds are received. During the three months ended January 31, 2024, the Company has recorded a recovery of $2,400 received in the period as a reduction of legal expenses (2023 - $2,400).

(c) On November 1, 2023, a former employee filed a statement of claim against the Company relating to employment termination without reasonable notice. The Company filed a statement of defence and counterclaim on November 29, 2023 denying all liability to the former employee. The Company considers the claim of the former employee to be largely and likely without merit and therefore, no provision has been recorded in these unaudited condensed interim consolidated financial statements.

(d) On March 23, 2023, the Company signed a letter of intent (the "LOI") with companies incorporated in Romania (the "Parties") whereby the Parties intend to collaborate for the development of certain hardware equipment (the "Project"). Under the LOI, the Parties will provide full payment for the hardware equipments and the Company will provide all engineering support and expertise as required. At January 31, 2024 a formal agreement relating to the Project has not yet been executed.

In relation to the construction of the hardware equipment, the Company has recorded at January 31, 2024 and October 31, 2023, total advances received from the Parties of $63,000 as a deposit liability and the third party payments of $63,000 as a prepaid expense on the unaudited condensed interim consolidated statement of financial position.

At January 31, 2024 the Company is committed to a further $63,000 payment related to the construction of the hardware equipment.


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

19. Capital risk management

The Company's objectives when managing capital are to (i) maintain its ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders, (ii) ensure it has sufficient cash resources to further develop and market its technologies and (iii) maintain its ongoing operations. The Company defines its capital as its net assets, i.e. total assets less total liabilities. In order to secure the additional capital necessary to pursue these objectives, the Company may attempt to raise additional funds through the issuance of equity or convertible debentures or by securing strategic partners. The Company is not subject to externally imposed capital requirements and there has been no change with respect to the overall capital risk management strategy during the three month period ended January 31, 2024.

20. Financial risk management

(a) Currency risk

Currency risk is the risk that the fair value of, or future cash flows from, the Company's financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to currency risk to the extent that it incurs expenses and issues convertible debentures denominated in Canadian dollars (CAD). The Company manages currency risk by monitoring the Canadian dollar position of these monetary financial instruments on a periodic basis throughout the course of the reporting period.

As at January 31, 2024, and October 31, 2023, balances that are denominated in CAD are as follows:

    As at     As at  
    January 31,     October 31,  
    2024     2023  
    CAD     CAD  
Cash $ 27,097   $ 38,444  
Other receivables $ 18,084   $ 29,080  
Trade payables and other liabilities $ 316,215   $ 290,311  
Convertible debentures $ 2,564,104   $ 2,544,289  
Debenture payable $ 52,031   $ 52,031  
Derivative liabilities $ 2,339,849   $ 1,087,044  
Long-term loan $ 60,000   $ 60,000  

A 10% strengthening of the US dollar against the CAD would decrease net loss and comprehensive loss by $359,000 as at January 31, 2024, (October 31, 2023 - decrease net loss and comprehensive loss by $260,000). A 10% weakening of the USD against the CAD would have the opposite effect of the same magnitude.

(b) Interest rate risk

Interest rate risk is the risk that the fair value of, or future cash flows from, the Company's financial instruments will significantly fluctuate due to changes in market interest rates. The Company is exposed to interest rate risk on its interest-bearing convertible debentures. This exposure is limited due to the short-term nature of the convertible debentures.

(c) Credit risk

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from the Company's cash. The maximum exposure to credit risk is the carrying value of these financial assets, which amounted to $34,189 as at January 31, 2024 (October 31, 2023 - $43,289). The Company reduces its credit risk by assessing the credit quality of counterparties, taking into account their financial position, past experience and other factors.

The risk for cash is mitigated by holding these balances with with central banks and financial institution counterparties that are highly rated. The Company therefore does not expect any credit losses on its cash.

The risk of credit loss on receivable is substantially mitigated by assessing the credit quality of counterparties, taking into account their financial position, past experience and other factors. Management actively monitors the Company's exposure to credit risk under its financial instruments, including with respect to other receivables.

16


Micromem Technologies Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

For the three months ended January 31, 2024 and 2023

(Expressed in United States dollars, unless otherwise noted)

 

20. Financial risk management (continued)

(d) Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company's policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company's management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. With the exception of the long-term loan, all financial liabilities are due within 1 year as at January 31, 2024.

(i) Trade payables

The following represents an analysis of the maturity of trade payables:

    As at     As at  
    January 31,     October 31,  
    2024     2023  
Less than 30 days past billing date $ 234,977   $ 209,285  
  $ 234,977   $ 209,285  

(ii) Convertible debentures and derivative liabilities

The following represents an analysis of the maturity of the convertible debentures and derivative liabilities:

    As at January 31,     As at October 31,  
    2024     2023  
    Convertible           Convertible        
    debentures   Debenture payable     debentures   Debenture payable  
Less than three months $ 2,222,073   $ -   $ 2,451,614   $ 37,509  
Three to six months   1,567,038     38,836     1,038,355     -  
Six to twelve months   150,193     -     433,815     -  
  $ 3,939,304   $ 38,836   $ 3,923,784   $ 37,509  

20. Subsequent events

Subsequent to January 31, 2024:

(a) The Company extended its convertible debentures, with an original maturity date in February, 2024, for an additional 6 months, expiring in August, 2024. There were no significant changes to the terms of the convertible debentures as a result of the extension.